ProfileGDS5678 / 1438742_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 46% 46% 46% 42% 46% 47% 60% 51% 46% 46% 45% 43% 49% 46% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.1296746
GSM967853U87-EV human glioblastoma xenograft - Control 23.0824746
GSM967854U87-EV human glioblastoma xenograft - Control 33.0706746
GSM967855U87-EV human glioblastoma xenograft - Control 42.9031342
GSM967856U87-EV human glioblastoma xenograft - Control 53.0177646
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.2031647
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.6971160
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.2220651
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.0541746
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.0648246
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.038945
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.9595143
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.1616749
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.0730646